RC
Russell Clayton bought $10K of LRMR stock
Russell Clayton, Chief Medical Officer of Larimar Therapeutics, Inc. (LRMR), bought 3,322 shares of LRMR stock worth $10K, per an SEC Form 4 filed Nov 18, 2026.
It was an open-market purchase.
The trade happened on Nov 16, 2026, 2 days before it was made public.
LRMR has moved +4.7% since the trade date, from $3.00 to $3.14 (Nov 20, 2026 close).
- Traded
- Nov 16, 2026
- Disclosed
- Nov 18, 2026
- Filing delay
- 2 days
- Price since
- +4.7%
- Role
- Chief Medical Officer
- Source
- SEC Form 4